Literature DB >> 26034608

Integration of palliative care into the neuro-oncology practice: patterns in the United States.

Tobias Walbert1.   

Abstract

BACKGROUND: Between 80%-85 percent of all adult brain tumors are high-grade gliomas (HGGs). Despite aggressive treatment with surgical resection, radiotherapy and chemotherapy, the survival of patients with HGG is limited. Brain tumor patients develop unique symptoms and needs throughout their disease trajectory, and the majority lose the ability to communicate during the end-of-life phase. Palliative care (PC) is a proactive and systematic approach to manage issues that are important to patients and families affected by serious illness. The goal is to improve quality of life and symptom control and thereby reduce suffering. Most PC interventions take place during the end-of-life phase; however, newer data suggest that early PC interventions might improve symptom control and quality of life.
METHODS: A literature review focusing on PC, hospice care, and end-of-life care was performed with the aim to describe the integration of PC into neuro-oncology practice.
RESULTS: Recently there has been increased interest in the effects of PC and brain tumor patients. The origins, methodology, and conceptual models of delivering PC and how it might be applied to the field of neuro-oncology were reviewed. Patterns of referral and utilization in neuro-oncology are described based on the findings of a recent survey.
CONCLUSIONS: Despite a very high symptom burden, many HGG patients do not receive the same level of PC and have fewer interactions with PC services than other cancer populations. Early PC interventions and structured advance-care planning might improve symptom control and quality of life for brain tumor patients.

Entities:  

Keywords:  end-of-life; glioblastoma; glioma; palliative care; supportive care

Year:  2014        PMID: 26034608      PMCID: PMC4369700          DOI: 10.1093/nop/npt004

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN: 2054-2577


  31 in total

1.  Integrating supportive and palliative care in the trajectory of cancer: establishing goals and models of care.

Authors:  Eduardo Bruera; David Hui
Journal:  J Clin Oncol       Date:  2010-07-26       Impact factor: 44.544

2.  Availability and integration of palliative care at US cancer centers.

Authors:  David Hui; Ahmed Elsayem; Maxine De la Cruz; Ann Berger; Donna S Zhukovsky; Shana Palla; Avery Evans; Nada Fadul; J Lynn Palmer; Eduardo Bruera
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

3.  Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center.

Authors:  Shalini Dalal; Shana Palla; David Hui; Linh Nguyen; Ray Chacko; Zhijun Li; Nada Fadul; Cheryl Scott; Veatra Thornton; Brenda Coldman; Yazan Amin; Eduardo Bruera
Journal:  Oncologist       Date:  2011-01-06

4.  Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center.

Authors:  Nada Fadul; Ahmed Elsayem; J Lynn Palmer; Egidio Del Fabbro; Kay Swint; Zhijun Li; Valerie Poulter; Eduardo Bruera
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

5.  A study of patients with a primary malignant brain tumour and their carers: symptoms and access to services.

Authors:  Anne Arber; Sara Faithfull; Marek Plaskota; Caroline Lucas; Kay de Vries
Journal:  Int J Palliat Nurs       Date:  2010-01

6.  Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.

Authors:  Terri S Armstrong; Jeffrey S Wefel; Meihua Wang; Mark R Gilbert; Minhee Won; Andrew Bottomley; Tito R Mendoza; Corneel Coens; Maria Werner-Wasik; David G Brachman; Ali K Choucair; Minesh Mehta
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

7.  Variability in access to hospital palliative care in the United States.

Authors:  Benjamin Goldsmith; Jessica Dietrich; Qingling Du; R Sean Morrison
Journal:  J Palliat Med       Date:  2008-10       Impact factor: 2.947

8.  Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide.

Authors:  Giuseppe Minniti; Claudia Scaringi; Alessandra Baldoni; Gaetano Lanzetta; Vitaliana De Sanctis; Vincenzo Esposito; Riccardo Maurizi Enrici
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-06-01       Impact factor: 7.038

9.  Epilepsy in the end-of-life phase in patients with high-grade gliomas.

Authors:  Andrea Pace; Veronica Villani; Cherubino Di Lorenzo; Lara Guariglia; Marta Maschio; Alfredo Pompili; Carmine Maria Carapella
Journal:  J Neurooncol       Date:  2012-10-20       Impact factor: 4.130

10.  Does referral to specialist paediatric palliative care services reduce hospital admissions in oncology patients at the end of life?

Authors:  L K Fraser; M van Laar; M Miller; J Aldridge; P A McKinney; R C Parslow; R G Feltbower
Journal:  Br J Cancer       Date:  2013-02-28       Impact factor: 7.640

View more
  21 in total

1.  Palliative care education in U.S. adult neuro-oncology fellowship programs.

Authors:  Ambereen K Mehta; Natalie May; Sarah Verga; Camilo E Fadul
Journal:  J Neurooncol       Date:  2018-08-02       Impact factor: 4.130

2.  Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey.

Authors:  Tobias Walbert; Michael Glantz; Lonni Schultz; Vinay K Puduvalli
Journal:  J Neurooncol       Date:  2015-10-30       Impact factor: 4.130

3.  Neurosurgical patients admitted via the emergency department initiating comfort care measures: a prospective cohort analysis.

Authors:  Joseph R Linzey; Rachel Foshee; Sudharsan Srinivasan; Arjun R Adapa; Meghan L Wind; Carina Brake; Badih Junior Daou; Kyle Sheehan; Thomas C Schermerhorn; Teresa L Jacobs; Aditya S Pandey
Journal:  Acta Neurochir (Wien)       Date:  2020-08-21       Impact factor: 2.216

4.  Simultaneous care in neuro-oncology.

Authors:  Andrea Pace; Tobias Walbert
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

5.  Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting.

Authors:  Mirjam Renovanz; Marlene Hechtner; Mareile Janko; Karoline Kohlmann; Jan Coburger; Minou Nadji-Ohl; Jochem König; Florian Ringel; Susanne Singer; Anne-Katrin Hickmann
Journal:  J Neurooncol       Date:  2017-05-19       Impact factor: 4.130

6.  Hospice utilization in patients with malignant gliomas.

Authors:  Deborah Forst; Eric Adams; Ryan Nipp; Allison Martin; Areej El-Jawahri; Ayal Aizer; Justin T Jordan
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

7.  Comparison of the quality of death between primary malignant brain tumor patients and other cancer patients: results from a nationwide bereavement survey in Japan.

Authors:  Maho Aoyama; Kento Masukawa; Ikuko Sugiyama; Tatsuya Morita; Yoshiyuki Kizawa; Satoru Tsuneto; Yasuo Shima; Mitsunori Miyashita
Journal:  J Neurooncol       Date:  2022-04-18       Impact factor: 4.130

8.  A proposed framework of supportive and palliative care for people with high-grade glioma.

Authors:  Jennifer Philip; Anna Collins; Caroline Brand; Vijaya Sundararajan; Carrie Lethborg; Michelle Gold; Rosalind Lau; Gaye Moore; Michael Murphy
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

9.  Compliance with patient-reported outcome assessment in glioma patients: predictors for drop out.

Authors:  Mirjam Renovanz; Marlene Hechtner; Karoline Kohlmann; Mareile Janko; Minou Nadji-Ohl; Susanne Singer; Florian Ringel; Jan Coburger; Anne-Katrin Hickmann
Journal:  Neurooncol Pract       Date:  2017-10-31

10.  The views of patients with brain cancer about palliative care: a qualitative study.

Authors:  M Vierhout; M Daniels; P Mazzotta; J Vlahos; W P Mason; M Bernstein
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.